{"id":"https://openalex.org/G41570684","display_name":"TrkB neurotrophin receptor as a drug target","description":"Neuronal plasticity is critical for learning and memory, but also for the antidepressant drug action. We recently found that essentially all antidepressants act by directly binding to TrkB, the receptor for brain-derived neurotrophic factor (BDNF) and enhancing BDNF signalling and neuroplasticity. As certain serotonin receptor agonists have been reported to produce long-lasting antidepressant effects, we will here study whether these serotonin agonists and serotonin itself might bind to TrkB and promote BDNF signalling. We will reveal the detailed structure of the binding site in TrkB and study whether the antidepressant and plasticity-promoting effects of these drugs are mediated by TrkB.  We will then search for novel compounds that bind to TrkB with high affinity and selectivity. We believe that these selective high-affinity TrkB ligands could become the next generation antidepressant and plasticity enhancing drugs, producing a paradigm shift in the drug treatment of depression.","funder_award_id":"347358","funder":{"id":"https://openalex.org/F4320321108","display_name":"Academy of Finland","doi":"https://doi.org/10.13039/501100002341"},"funded_outputs":["https://openalex.org/W4307857612","https://openalex.org/W4308768859","https://openalex.org/W4328127676","https://openalex.org/W4389858032","https://openalex.org/W4402624198","https://openalex.org/W4410891762"],"funded_outputs_count":6,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":500000.0,"currency":"EUR","amount_usd":566300.0,"amount_usd_basis":"daily_rate","recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"grant","funder_scheme":"Academy Project Funding 2021","start_date":"2022-01-01","end_date":"2026-08-31","start_year":2022,"end_year":2026,"landing_page_url":"https://research.fi/en/results/funding/69780","doi":null,"provenance":"researchfi","lead_investigator":{"given_name":"Eero","family_name":"Castren","orcid":"0000-0002-1402-2791","role_start":null,"affiliation":{"name":"University of Helsinki","country":"Finland","ids":null},"author":{"id":"https://openalex.org/A5019744869","display_name":"Eero \u010aastr\u00e9n","orcid":"https://orcid.org/0000-0002-1402-2791"},"institutions":null},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G41570684","primary_topic":{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.5757,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.5757,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.4109,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0037,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trkb-receptor","display_name":"TrkB receptor","score":0.952},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.982},{"id":"https://openalex.org/keywords/serotonin-receptor-agonists","display_name":"serotonin receptor agonists","score":0.776},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.742},{"id":"https://openalex.org/keywords/neuroplasticity","display_name":"neuroplasticity","score":0.836},{"id":"https://openalex.org/keywords/bdnf-signalling","display_name":"BDNF signalling","score":0.756},{"id":"https://openalex.org/keywords/binding-site-structure","display_name":"binding site structure","score":0.784},{"id":"https://openalex.org/keywords/depression-treatment","display_name":"depression treatment","score":0.815},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.409}],"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537,"id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[],"updated_date":"2026-11-18T03:00:59.000Z","created_date":"2026-07-13T04:53:04.000Z"}
